EUVIMEDEUVIMED entdecken
Open Access

Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification

Jane E Blackmer iD, Erin A Jezuit, Archan Chakraborty iD, Satya N Yalamanchi iD, Ruth A Montague, Erin E Dickert, Nora G Peterson, William Outlaw, Donald T Fox iD

GENETICS · 2025

DOI: 10.1093/genetics/iyaf148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GENETICS, 2025. Verfasst von Jane E Blackmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Duke University, DUMC Box 3813, Durham, NC 27710, United States. Hauptthemen laut MEDLINE: Centrosome, Aneuploidy, Drosophila Proteins, Nerve Tissue Proteins. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NASA Translational Institute for Space Health (TRISH), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amplified centrosome number causes genomic instability, most severely through division into >2 aneuploid daughter cells (multipolar mitosis). Several mechanisms that suppress multipolar division have been uncovered, yet mechanisms that favor viable multipolar division are poorly understood. To uncover factors that promote viability in cells with frequent centrosome amplification and multipolar division, we conducted an unbiased Drosophila genetic screen. In 642 mutagenized lines, we exploited the ability of intestinal papillar cells to form and function despite multipolar divisions. Our top hit is an unnamed gene, CG3168. We name this gene synaptic vesicle glycoprotein 2, reflecting homology to human Synaptic Vesicle Glycoprotein 2 (SV2) proteins. GFP-tagged SV2 localizes to the plasma membrane. In cells with amplified centrosomes, SV2 positions membrane-adjacent centrosomes, which prevents severe errors in chromosome alignment and segregation. Our results uncover membrane-based multipolar division regulation and reveal a novel vulnerability in cells with common cancer properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CentrosomeAneuploidyDrosophila ProteinsNerve Tissue ProteinsAnimalsChromosome SegregationDrosophila melanogasterHumansMitosisDrosophilaCell Membrane

Stichwörter der Autor:innen

Drosophila melanogasterEMSaneuploidycentrosomecentrosome amplificationgenetics screenmitosismultipolar divisionsynaptic vesicle glycoprotein 2

Substanzen

Drosophila ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Duke University, DUMC Box 3813, Durham, NC 27710, United States.

ORCID-Profile: Jane E Blackmer, Archan Chakraborty, Satya N Yalamanchi, Donald T Fox

Förderung

  • NIGMS NIH HHS
  • NASA Translational Institute for Space Health (TRISH)
  • NIH HHS
  • NIH

Zitieren

APA

Blackmer, J. E., Jezuit, E. A., Chakraborty, A., Yalamanchi, S. N., Montague, R. A., Dickert, E. E., Peterson, N. G., Outlaw, W., & Fox, D. T. (2025). Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. GENETICS. https://doi.org/10.1093/genetics/iyaf148

Vancouver

Blackmer JE, Jezuit EA, Chakraborty A, Yalamanchi SN, Montague RA, Dickert EE, et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. GENETICS. 2025. doi:10.1093/genetics/iyaf148

BibTeX
@article{Blackmer2025,
  author = {Blackmer, Jane E and Jezuit, Erin A and Chakraborty, Archan and Yalamanchi, Satya N and Montague, Ruth A and Dickert, Erin E and Peterson, Nora G and Outlaw, William and Fox, Donald T},
  title = {Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification},
  journal = {GENETICS},
  year = {2025},
  doi = {10.1093/genetics/iyaf148}
}
Kostenlos starten →